JUNTEN BIO CO LTD has a total of 19 patent applications. Its first patent ever was published in 2019. It filed its patents most often in Australia, Canada and Taiwan. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are BIONTECH AG, BIAL IND FARMACEUTICA S A and INT INST CANCER IMMUNOLOGY INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 3 | |
#2 | Canada | 3 | |
#3 | Taiwan | 3 | |
#4 | WIPO (World Intellectual Property Organization) | 3 | |
#5 | EPO (European Patent Office) | 2 | |
#6 | Brazil | 1 | |
#7 | Israel | 1 | |
#8 | Japan | 1 | |
#9 | Republic of Korea | 1 | |
#10 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds | |
#4 | Microorganisms | |
#5 | Measuring microorganism processes | |
#6 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Okumura Ko | 17 |
#2 | Takeda Kazuyoshi | 16 |
#3 | Uchida Koichiro | 16 |
#4 | Maeda Ryu | 6 |
#5 | Kawakami Masayuki | 6 |
#6 | Yamashita Kenichiro | 2 |
#7 | Koichiro Uchida | 1 |
#8 | Okumura Yasushi | 1 |
#9 | Kazuyoshi Takeda | 1 |
#10 | Masayuki Kawakami | 1 |
Publication | Filing date | Title |
---|---|---|
US2020079853A1 | T regulatory cells and uses thereof | |
KR20210025062A | Cell therapy therapy using antibodies, induced lymphocytes, and induced lymphocytes that induce immune tolerance | |
WO2019245038A1 | Antibody capable of inducing immune tolerance produced using cell mixture having complexed state, and induced lymphocyte or cell therapeutic agent and cell therapy method each using induced lymphocyte | |
TW202015709A | Composition for eliciting infectious immunological tolerance |